Literature DB >> 25458334

Clinical implications of linear immunofluorescent staining for immunoglobulin G in patients with diabetic nephropathy.

Koki Mise1, Junichi Hoshino2, Toshiharu Ueno2, Keiichi Sumida2, Rikako Hiramatsu2, Eiko Hasegawa2, Masayuki Yamanouchi2, Noriko Hayami2, Tatsuya Suwabe2, Naoki Sawa2, Takeshi Fujii3, Shigeko Hara2, Kenichi Ohashi4, Kenmei Takaichi5, Yoshifumi Ubara5.   

Abstract

AIMS: The kidneys of patients with diabetes mellitus usually exhibit a characteristic pattern of linear immunofluorescent staining for immunoglobulin G (IgG) along the glomerular and tubular basement membranes. However, the association between linear IgG staining and the renal prognosis remains unclear.
METHODS: Among 223 patients with diabetes who underwent renal biopsy from 1985 to 2010 and were confirmed to have pure diabetic nephropathy according to the classification of Tervaert et al., 165 patients (glomerular classes I to III) were enrolled in this study. Immunofluorescent staining was classified into three categories according to its intensity (0=none, 1=weakly positive, and 2=positive). Cox proportional hazards regression analysis was used to calculate the hazard ratio (HR) and 95% confidence interval (CI) for death-censored renal death, with each regression analysis employing four levels of multivariate adjustment.
RESULTS: After adjustment for important clinical factors at the time of renal biopsy, the HR for death-censored renal death in patients with an IgG staining score of 1 or 2 was, respectively, 3.01 (95% CI: 1.05-8.68) and 4.68 (1.67-13.1) compared with patients who had a staining score of 0. Even after adjustment for clinical variables and pathological findings, the HR for IgG score of 1 or 2 was higher than that for an IgG score of 0, and it was, respectively, 2.22 (0.71-7.00) and 3.76 (1.27-11.2).
CONCLUSIONS: More intense linear IgG staining is associated with a higher HR for renal death, which suggests that linear immunofluorescent staining for IgG may be a prognostic indicator in patients with diabetic nephropathy.
Copyright © 2014 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Keywords:  Diabetic nephropathy; Linear immunofluorescent IgG staining; Pathology; Renal biopsy; Renal prognosis

Mesh:

Substances:

Year:  2014        PMID: 25458334     DOI: 10.1016/j.diabres.2014.09.051

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  10 in total

Review 1.  Role of the Immune System in Diabetic Kidney Disease.

Authors:  Fionnuala B Hickey; Finian Martin
Journal:  Curr Diab Rep       Date:  2018-03-12       Impact factor: 4.810

2.  Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy.

Authors:  Koki Mise; Junichi Hoshino; Toshiharu Ueno; Ryo Hazue; Jumpei Hasegawa; Akinari Sekine; Keiichi Sumida; Rikako Hiramatsu; Eiko Hasegawa; Masayuki Yamanouchi; Noriko Hayami; Tatsuya Suwabe; Naoki Sawa; Takeshi Fujii; Shigeko Hara; Kenichi Ohashi; Kenmei Takaichi; Yoshifumi Ubara
Journal:  Clin J Am Soc Nephrol       Date:  2016-01-22       Impact factor: 8.237

Review 3.  Advances in fluorescence microscopy techniques to study kidney function.

Authors:  Suman Ranjit; Luca Lanzanò; Andrew E Libby; Enrico Gratton; Moshe Levi
Journal:  Nat Rev Nephrol       Date:  2020-09-18       Impact factor: 28.314

4.  Paratubular basement membrane insudative lesions predict renal prognosis in patients with type 2 diabetes and biopsy-proven diabetic nephropathy.

Authors:  Koki Mise; Yutaka Yamaguchi; Junichi Hoshino; Toshiharu Ueno; Akinari Sekine; Keiichi Sumida; Masayuki Yamanouchi; Noriko Hayami; Tatsuya Suwabe; Rikako Hiramatsu; Eiko Hasegawa; Naoki Sawa; Takeshi Fujii; Shigeko Hara; Hitoshi Sugiyama; Hirofumi Makino; Jun Wada; Kenichi Ohashi; Kenmei Takaichi; Yoshifumi Ubara
Journal:  PLoS One       Date:  2017-08-15       Impact factor: 3.240

Review 5.  Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy.

Authors:  Sandra Rayego-Mateos; José Luis Morgado-Pascual; Lucas Opazo-Ríos; Melania Guerrero-Hue; Cristina García-Caballero; Cristina Vázquez-Carballo; Sebastián Mas; Ana Belén Sanz; Carmen Herencia; Sergio Mezzano; Carmen Gómez-Guerrero; Juan Antonio Moreno; Jesús Egido
Journal:  Int J Mol Sci       Date:  2020-05-27       Impact factor: 5.923

6.  Kidney biopsy guidebook 2020 in Japan.

Authors:  Yoshifumi Ubara; Takehiko Kawaguchi; Tasuku Nagasawa; Kenichiro Miura; Takayuki Katsuno; Takashi Morikawa; Eiji Ishikawa; Masao Ogura; Hideki Matsumura; Ryota Kurayama; Shinsuke Matsumoto; Yuhji Marui; Shigeo Hara; Shoichi Maruyama; Ichiei Narita; Hirokazu Okada; Kazuhiko Tsuruya
Journal:  Clin Exp Nephrol       Date:  2021-04       Impact factor: 2.801

7.  Association Between Diabetes and Major Bleeding Complications of Renal Biopsy.

Authors:  Sho Hasegawa; Akira Okada; Shotaro Aso; Ryosuke Kumazawa; Hiroki Matsui; Kiyohide Fushimi; Hideo Yasunaga; Masaomi Nangaku
Journal:  Kidney Int Rep       Date:  2021-11-25

8.  IgG subclass deposition in diabetic nephropathy.

Authors:  Xuanli Tang; Feng Wan; Qin Zhu; Tian Ye; Xue Jiang; Haichun Yang
Journal:  Eur J Med Res       Date:  2022-08-11       Impact factor: 4.981

9.  Immune repertoire and evolutionary trajectory analysis in the development of diabetic nephropathy.

Authors:  Zheng Ye; Yidi Zhang; Nan Huang; Shen Chen; Xiaodong Wu; Ling Li
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

Review 10.  Introduction to clinical research based on modern epidemiology.

Authors:  Junichi Hoshino
Journal:  Clin Exp Nephrol       Date:  2020-03-24       Impact factor: 2.801

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.